Loading clinical trials...
Loading clinical trials...
Phase I Study of AR-42 in Relapsed Myeloma, Chronic Lymphocytic Leukemia, and Lymphoma
Conditions
Interventions
Pharmacodynamic Studies
Fatigue Inventory
+2 more
Locations
1
United States
The Ohio State University James Cancer Hospital
Columbus, Ohio, United States
Start Date
May 4, 2010
Primary Completion Date
January 7, 2017
Completion Date
January 7, 2017
Last Updated
June 4, 2018
NCT07388563
NCT06561048
NCT04195633
NCT04925609
NCT00336063
NCT03278782
Lead Sponsor
Amir Mortazavi
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions